|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Viral Research Corp., of Yonkers, N.Y., said it began to recruit sites for its Phase II study of product R for the topical treatment of genital warts. The company submitted Phase I data to the FDA and no adverse comments were received from the FDA. Phase I results indicated that Product R was safe and well tolerated dermatologically in all the doses applied in the study.
Axcan Pharma Inc., of Mont Saint-Hilaire, Quebec, filed a marketing authorization application with the Evaluation of Medicinal Products Agency in Europe for the use of its photodynamic therapy, Photobarr (porfimer sodium), in high-grade dysplasia associated with BarrettEs esophagus. ...
Related newspaper, magazine, and journal articles:
|
|
Article: Dainippon Sumitomo Pharma America Opts for SAS ...
Health & Beauty Close-Up;
November 4, 2009 ;
434 words
...SAS announced that Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform ...
|
|